🏛️ Verified NIH Record • Updated 2026-07-14

Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia (NCT06449378)

Multi-center, Single-arm, Prospective Study of Transorb™ Self-Gripping REsorbable Mesh in High-risk subjeCts Undergoing Open Repair of VEntral heRnia

🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Medtronic - MITG

🩺 Plain-English Summary (8th-Grade Level)

The purpose of RECOVER is to evaluate the performance and safety of Transorb™ self-gripping resorbable mesh in high-risk subjects (at least one risk factor impairing wound healing) when used for reinforcement of abdominal wall soft tissues in procedures involving open extraperitoneal ventral hernia repair, in clean (US); and clean and clean-contaminated (Europe) surgical fields (Centers for Disease Control and Prevention (CDC) Classification I and II. Data from this study will primarily be used to support market approval and European post-market clinical follow-up needs. Secondarily, data will be used for product marketing, future product development, and to support market release and maintenance in global geographies.

Who can join: Review the eligibility criteria below.

Location: Northwestern University — Evanston, Illinois

Age range: 18 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (13 Sites)

  • Northwestern University — Evanston, Illinois
  • University of Kentucky — Lexington, Kentucky
  • Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina
  • Cleveland Clinic Foundation — Cleveland, Ohio
  • The Ohio State University — Columbus, Ohio
  • TPMG General Surgery and Hernia Center — Newport News, Virginia
  • UZ Leuven, campus Gasthuisberg — Leuven,
  • APHP Hospital Louis Mourier — Colombes,
  • Centre Hospitalier Universitaire de Lille — Lille,
  • Hospices Civils de Lyon — Lyon,
  • Centre Hospitalier Universitaire de Reims — Reims,
  • Hôpital Charles Nicolle Centre Hospitalier Universitaire de Rouen — Rouen,
  • Hôpitaux Universitaires de Strasbourg — Strasbourg,

📞 Contact the Study Coordinator

Phone: (855) 692-6482

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Hernia clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗